T1	Disease	44 70	EGFR -mutant lung cancer ,
T2	Chemical	108 141	afatinib plus cetuximab delivered
T3	Disease	178 226	( L858R ) - induced lung adenocarcinomas delayed
T4	Disease	227 240	tumor relapse
T5	Phenotype	227 244	tumor relapse and
T6	Pharmacodynamic_phenotype	245 269	drug-resistance compared
T7	Chemical	293 294	.
R1	isAssociatedWith	Arg1:T1	Arg2:T3
R2	influences	Arg1:T1	Arg2:T4
R3	influences	Arg1:T1	Arg2:T5
R4	influences	Arg1:T1	Arg2:T6
R5	isAssociatedWith	Arg1:T1	Arg2:T7
R6	treats	Arg1:T2	Arg2:T1
R7	treats	Arg1:T2	Arg2:T3
R8	influences	Arg1:T2	Arg2:T4
R9	influences	Arg1:T2	Arg2:T5
R10	influences	Arg1:T2	Arg2:T6
R11	influences	Arg1:T2	Arg2:T7
R12	treats	Arg1:T3	Arg2:T1
R13	influences	Arg1:T3	Arg2:T2
R14	influences	Arg1:T3	Arg2:T4
R15	influences	Arg1:T3	Arg2:T5
R16	influences	Arg1:T3	Arg2:T6
R17	influences	Arg1:T3	Arg2:T7
R18	isAssociatedWith	Arg1:T4	Arg2:T1
R19	influences	Arg1:T4	Arg2:T2
R20	isAssociatedWith	Arg1:T4	Arg2:T3
R21	influences	Arg1:T4	Arg2:T5
R22	isAssociatedWith	Arg1:T4	Arg2:T7
R23	influences	Arg1:T5	Arg2:T2
R24	isAssociatedWith	Arg1:T5	Arg2:T3
R25	influences	Arg1:T5	Arg2:T4
R26	influences	Arg1:T5	Arg2:T6
R27	isAssociatedWith	Arg1:T5	Arg2:T7
R28	isAssociatedWith	Arg1:T6	Arg2:T1
R29	isAssociatedWith	Arg1:T6	Arg2:T2
R30	isAssociatedWith	Arg1:T6	Arg2:T3
R31	isAssociatedWith	Arg1:T6	Arg2:T4
R32	isAssociatedWith	Arg1:T6	Arg2:T5
R33	isAssociatedWith	Arg1:T6	Arg2:T7
R34	influences	Arg1:T7	Arg2:T2
R35	isAssociatedWith	Arg1:T7	Arg2:T3
R36	influences	Arg1:T7	Arg2:T4
R37	influences	Arg1:T7	Arg2:T5
R38	influences	Arg1:T7	Arg2:T6
